Tag: chronic cough market outlook

  • Chronic Cough Market Overview 2024: Size, Growth Drivers, and Major Segments

    Chronic Cough Market Overview 2024: Size, Growth Drivers, and Major Segments

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    What is the Expected Growth Rate of the Chronic Cough Market for the Period 2024 to 2033?

    In recent years, the market size for chronic cough has been expanding significantly. It’s predicted to escalate from $7.5 billion in 2023 to $8.16 billion in 2024, displaying a compound annual growth rate (CAGR) of 8.8%. Several factors could be contributing to this historic growth period, including a high prevalence of respiratory diseases, environmental contributors and air pollution, the usage of tobacco and smoking, respiratory illnesses, sensitivities to allergens and environmental conditions.

    There is a projection for significant expansion in the chronic cough market over the next few years, with forecasts of it ballooning to $11.48 billion by 2028, reflecting a compound annual growth rate (CAGR) of 8.9%. This anticipated growth during the predicted period can be credited to emerging treatments that target specific channels, increased recognition of reflux-induced cough, global initiatives supporting smoking cessation, and policies related to environmental and occupational health. The projected period also highlights significant trends such as progress in diagnostic technologies, approaches centered around patients, therapeutic breakthroughs in neurogenic cough, the application of telehealth in managing chronic cough, and sensitization research on a central level.

    Claim Your Free Sample of the Global Chronic Cough Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=12109&type=smp

    What Factors Are Responsible for the Growth of the chronic cough Market?

    The increase in cough incidents is anticipated to drive the expansion of the chronic cough market. Coughing is a reflex reaction that often occurs in response to irritation, mucus, or foreign bodies, which cleanses the airways by forcefully expelling air from the lungs. A persistent cough lasting for at least eight weeks is termed as chronic. Consequently, as the frequency of coughing increases, so does the incidence of chronic cough. For example, the Florida Health, a department of healthcare in the US, recorded a total of 80 patients with chronic cough incidences in 2021 with rates of 41.0 and 1.4 per 100,000 years respectively. Moreover, in 2023, there were 28 cases of pertussis registered across 13 countries. In March 2022, the number of pertussis cases recorded by the Statens Serum Institut, a Disease Surveillance Department based in Denmark, increased by 41% from November 2022 to April 2023, compared to the same period a year earlier. Thus, the escalating occurrence of coughs fuels the growth of the chronic cough market.

    Which Segments Are Important for Insight into the Chronic Cough Market?

    1) By Drug Class: Antihistamines, Corticosteroids, Decongestants, Combination Drug, Antibiotics, Acid Blockers, Other Drug Classes

    2) By Route Of Administration: Oral, Inhalational, Injectable, Other Route of Administrations

    3) By End-Users: Hospitals, Homecare, Specialty Centers, Other End Users

    4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

    What Are the Significant Trends Reshaping the Chronic Cough Sector?

    Leading firms in the chronic cough industry are focusing their efforts on crafting innovative items such as cough medication, with the aim of solidifying their market position. The function of this kind of syrup is to aide in the alleviation of upper respiratory allergies and the common cold, as it contains non-narcotic cough inhibitors which influence the brain’s cough center helping curb persistent coughing. For illustration, in September 2021, Sun Pharmaceutical Industries Limited, originating from India, introduced Chericof 12. This all-new cough treatment, the first-ever prescription cough medication to provide 12-hour relief. Chericof 12 is manufactured using the Polistirex technology, which ensures longer-lasting release of the medication, thereby enhancing patient adherence by avoiding changes in dosage. The Polistirex technology allows this formulation to combine two drugs, chlorpheniramine maleate and dextromethorphan hydrobromide, resulting in the drug’s gradual release thus offering extended relief from coughing.

    Order Now for Fast Delivery of Your Chronic Cough Market Report!

    https://www.thebusinessresearchcompany.com/report/chronic-cough-global-market-report

    Which Regions Are Essential for the Growth of the Chronic Cough Market?

    North America was the largest region in the chronic cough market in 2023. The regions covered in the chronic cough market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    The Chronic Cough Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the chronic cough market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Chronic Cough Market Include

    1. Chronic Cough Market Executive Summary

    2. Chronic Cough Market Segments

    3. Chronic Cough Market Size And Template Market Growth Rate

    4. Key Chronic Cough Market Trends

    5. Major Chronic Cough Market Drivers

    ……

    25. Key Mergers And Acquisitions In The Chronic Cough Market

    26. Top Chronic Cough Companies

    27. Chronic Cough Market Opportunities And Strategies

    28. Chronic Cough Market, Conclusions And Recommendations

    29. Appendix

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • What’s The Growth Forecast For Chronic Cough Market Through 2024-2033?

    What’s The Growth Forecast For Chronic Cough Market Through 2024-2033?

    The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

    Introduction

    The chronic cough market has experienced significant expansion in recent years, with promising growth projections on the horizon. Analyzing the factors driving this growth sheds light on the evolving landscape of chronic cough treatment.

    Current Market Landscape

    • The chronic cough market has witnessed robust growth, escalating from $7.5 billion in 2023 to $8.16 billion in 2024, boasting a Compound Annual Growth Rate (CAGR) of 8.8%.
    • Prevailing respiratory conditions, environmental factors, smoking habits, and allergies contribute to the market’s expansion.
    • Environmental pollution and respiratory infections further exacerbate the prevalence of chronic cough.

    Future Growth Prospects

    • Projections indicate continued growth, with the market expected to reach $11.48 billion by 2028, maintaining a CAGR of 8.9%.
    • Emerging therapies, advancements in diagnostic technologies, and global initiatives in smoking cessation drive future growth.
    • Innovative approaches targeting specific pathways and understanding reflux-related cough are pivotal in shaping the market’s trajectory.

    View More On The Chronic Cough Market Report 2024 – https://www.thebusinessresearchcompany.com/report/chronic-cough-global-market-report

    Major Trends Shaping the Future

    1. Advancements in Diagnostic Technologies
    2. Patient-Centric Approaches
    3. Innovations in Neurogenic Cough Treatment
    4. Telehealth for Chronic Cough Management
    5. Research on Central Sensitization

    Surging Prevalence of Cough Sparks Momentum

    • The rise in cough prevalence fuels the chronic cough market’s growth trajectory.
    • Persistent coughing, lasting at least eight weeks, signifies chronic cough, with underlying causes ranging from respiratory infections to environmental triggers.
    • Notable increases in cough incidences, as evidenced by data from various health agencies, underscore the market’s growth potential.

    Innovative Product Developments Transforming the Landscape

    • Major players in the chronic cough market are focused on developing innovative products to address the evolving needs of patients.
    • Sun Pharmaceutical Industries Limited’s launch of Chericof 12 exemplifies the industry’s commitment to offering advanced solutions.
    • Chericof 12, utilizing Polistirex technology, provides extended relief by gradually releasing medications, enhancing patient compliance and efficacy.

    Pfizer Expands Healthcare Technology Portfolio

    • Pfizer’s acquisition of ResApp Health signifies strategic efforts to bolster its healthcare technology offerings.
    • ResApp’s smartphone application analyzes cough patterns, aiding in the diagnosis of respiratory conditions, including chronic cough.
    • The acquisition expands Pfizer’s presence in crucial healthcare technology domains, positioning the company for further innovation and growth.

    Segmentation of the Chronic Cough Market

    1. By Drug Class: Antihistamines, Corticosteroids, Decongestants, Combination Drug, Antibiotics, Acid Blockers, Other Drug Classes
    2. By Route of Administration: Oral, Inhalational, Injectable, Other Route of Administrations
    3. By End-Users: Hospitals, Homecare, Specialty Centers, Other End Users
    4. By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

    North America Leads the Charge

    • North America emerged as the largest region in the chronic cough market in 2023, reflecting the region’s significant contribution to market expansion.

    Conclusion

    The chronic cough market’s growth trajectory is underpinned by a confluence of factors, including increasing prevalence, innovative product developments, and strategic acquisitions. With a focus on patient-centric approaches and technological advancements, the industry is poised for sustained growth, offering renewed hope for individuals grappling with chronic cough worldwide.

    Request A Sample Of The Global Chronic Cough Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=12109&type=smp